Gene Details | GeDiPNet - Complete Gene Info, Disease Associations & Pathways

Gene Gene miRNA Gene ontology Other IDs Protein Pathways Associated diseases
Entrez ID Entrez Gene ID - the GENE ID in NCBI Gene database.	344
Gene name Gene Name - the full gene name approved by the HGNC.	Apolipoprotein C2
Gene symbol Gene Symbol - the official gene symbol approved by the HGNC.	APOC2
Synonyms (NCBI Gene) Gene synonyms aliases	APO-CII, APOC-II
Chromosome Chromosome number	19
Chromosome location Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.	19q13.32
Summary Summary of gene provided in NCBI Entrez Gene.	This gene encodes a lipid-binding protein belonging to the apolipoprotein gene family. The protein is secreted in plasma where it is a component of very low density lipoprotein. This protein activates the enzyme lipoprotein lipase, which hydrolyzes trigly

Show/Hide all(17)

miRTarBase ID	miRNA	Experiments
MIRT2173212	hsa-miR-142-5p	CLIP-seq
MIRT2173213	hsa-miR-3907	CLIP-seq
MIRT2173214	hsa-miR-409-3p	CLIP-seq
MIRT2173215	hsa-miR-548a-5p	CLIP-seq
MIRT2173216	hsa-miR-548ab	CLIP-seq
MIRT2173217	hsa-miR-548ak	CLIP-seq
MIRT2173218	hsa-miR-548b-5p	CLIP-seq
MIRT2173219	hsa-miR-548c-5p	CLIP-seq
MIRT2173220	hsa-miR-548d-5p	CLIP-seq
MIRT2173221	hsa-miR-548h	CLIP-seq
MIRT2173222	hsa-miR-548i	CLIP-seq
MIRT2173223	hsa-miR-548j	CLIP-seq
MIRT2173224	hsa-miR-548k	CLIP-seq
MIRT2173225	hsa-miR-548l	CLIP-seq
MIRT2173226	hsa-miR-548w	CLIP-seq
MIRT2173227	hsa-miR-548y	CLIP-seq
MIRT2173228	hsa-miR-559	CLIP-seq

Show/Hide all(56)

GO ID	Ontology	Definition	Evidence	Reference
GO:0001523	Process	Retinoid metabolic process	TAS
GO:0005515	Function	Protein binding	IPI	32296183
GO:0005576	Component	Extracellular region	NAS	14718574
GO:0005576	Component	Extracellular region	TAS
GO:0005615	Component	Extracellular space	IDA	10727238
GO:0005769	Component	Early endosome	TAS
GO:0008289	Function	Lipid binding	IBA	21873635
GO:0008289	Function	Lipid binding	IDA	10727238
GO:0010518	Process	Positive regulation of phospholipase activity	IBA	21873635
GO:0010518	Process	Positive regulation of phospholipase activity	IDA	10727238
GO:0010898	Process	Positive regulation of triglyceride catabolic process	IDA	10727238
GO:0010902	Process	Positive regulation of very-low-density lipoprotein particle remodeling	IC	10727238
GO:0010916	Process	Negative regulation of very-low-density lipoprotein particle clearance	IBA	21873635
GO:0010916	Process	Negative regulation of very-low-density lipoprotein particle clearance	IDA	1917954
GO:0016004	Function	Phospholipase activator activity	IBA	21873635
GO:0016004	Function	Phospholipase activator activity	IDA	10727238
GO:0016042	Process	Lipid catabolic process	IEA
GO:0032375	Process	Negative regulation of cholesterol transport	IMP	15778093
GO:0033344	Process	Cholesterol efflux	IDA	11162594
GO:0033700	Process	Phospholipid efflux	IDA	11162594
GO:0034361	Component	Very-low-density lipoprotein particle	IBA	21873635
GO:0034361	Component	Very-low-density lipoprotein particle	IDA	8245722
GO:0034362	Component	Low-density lipoprotein particle	IBA	21873635
GO:0034362	Component	Low-density lipoprotein particle	IDA	8245722
GO:0034363	Component	Intermediate-density lipoprotein particle	IBA	21873635
GO:0034363	Component	Intermediate-density lipoprotein particle	IDA	17336988
GO:0034366	Component	Spherical high-density lipoprotein particle	IBA	21873635
GO:0034366	Component	Spherical high-density lipoprotein particle	IDA	16682745
GO:0034370	Process	Triglyceride-rich lipoprotein particle remodeling	TAS	17018885
GO:0034371	Process	Chylomicron remodeling	IC	10727238
GO:0034371	Process	Chylomicron remodeling	TAS
GO:0034372	Process	Very-low-density lipoprotein particle remodeling	TAS	15778093
GO:0034375	Process	High-density lipoprotein particle remodeling	TAS
GO:0034378	Process	Chylomicron assembly	TAS
GO:0034382	Process	Chylomicron remnant clearance	IBA	21873635
GO:0034382	Process	Chylomicron remnant clearance	IDA	4020294
GO:0034384	Process	High-density lipoprotein particle clearance	IBA	21873635
GO:0034384	Process	High-density lipoprotein particle clearance	IMP	15778093
GO:0042627	Component	Chylomicron	IBA	21873635
GO:0042627	Component	Chylomicron	IDA	8245722
GO:0042632	Process	Cholesterol homeostasis	IC	15778093
GO:0043086	Process	Negative regulation of catalytic activity	IEA
GO:0043274	Function	Phospholipase binding	IBA	21873635
GO:0043274	Function	Phospholipase binding	IPI	10727238
GO:0043691	Process	Reverse cholesterol transport	IC	15778093
GO:0045723	Process	Positive regulation of fatty acid biosynthetic process	IDA	10727238
GO:0045833	Process	Negative regulation of lipid metabolic process	IDA	182536
GO:0048261	Process	Negative regulation of receptor-mediated endocytosis	IDA	1917954
GO:0051006	Process	Positive regulation of lipoprotein lipase activity	IBA	21873635
GO:0051006	Process	Positive regulation of lipoprotein lipase activity	IDA	10727238, 15878877
GO:0055102	Function	Lipase inhibitor activity	IDA	182536
GO:0060230	Function	Lipoprotein lipase activator activity	IBA	21873635
GO:0060230	Function	Lipoprotein lipase activator activity	IDA	270715, 10727238
GO:0060697	Process	Positive regulation of phospholipid catabolic process	IBA	21873635
GO:0060697	Process	Positive regulation of phospholipid catabolic process	IDA	10727238
GO:0070328	Process	Triglyceride homeostasis	IMP	17018885

MIM	HGNC	e!Ensembl
608083	609	ENSG00000234906

Protein

UniProt ID

P02655

Protein name

Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II (ProapoC-II)]

Protein function

Component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL) in plasma. Plays an important role in lipoprotein metabolism as an activator of lipoprotein lipase. Both proapol

PDB

1BY6 , 1I5J , 1O8T , 1SOH

Family and domains

Pfam

Accession	ID	Position in sequence	Description	Type
PF05355	Apo-CII	24 → 100	Apolipoprotein C-II	Family

Tissue specificity

TISSUE SPECIFICITY: Liver and intestine. {ECO:0000269|PubMed:6546757}.

Sequence

MGTRLLPALFLVLLVLGFEVQGTQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYE
KTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE

Sequence length

101

Interactions

View interactions

	KEGG		Reactome
	Cholesterol metabolism		Chylomicron assembly Chylomicron remodeling HDL remodeling NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux Retinoid metabolism and transport

Show/Hide Causal Diseases (4)

Disease term	Disease name	dbSNP ID	References
Causal
Alzheimer disease	Alzheimer`s Disease	rs63750215, rs28936379, rs63749851, rs63749884, rs28936380, rs63750048, rs63750579, rs63750264, rs63749964, rs63750671, rs281865161, rs63750066, rs63750399, rs63750734, rs63751039 View all (65 more)	29777097
Amyloidosis	Amyloidosis	rs63750567, rs63750560, rs387906821, rs387906822, rs387906823, rs1561123748, rs140352180, rs770211260, rs763065333, rs1554300664, rs747723062, rs773435101	27297947
Apolipoprotein c2 deficiency	Familial apolipoprotein C-II deficiency, Apolipoprotein C-II Deficiency (disorder)	rs120074111, rs756916028, rs2122211012, rs111628497, rs120074112, rs120074115, rs120074116, rs754423238	24589565, 27604308, 27297947, 8323539
Hyperlipoproteinemia	Hyperlipoproteinemia Type I	rs118204056, rs118204057, rs118204058, rs118204059, rs1563572716, rs118204060, rs118204067, rs118204062, rs118204074, rs118204063, rs118204064, rs1563569634, rs118204065, rs118204066, rs1563575252 View all (36 more)

Show/Hide Unknown Diseases (1)

Disease term	Disease name	Evidence	References	Source
Unknown
Pancreatitis	Pancreatitis			ClinVar

Show/Hide Text Mining Associations (46)

Disease Name	Relationship Type	References
Associations from Text Mining
AA amyloidosis	Associate	27297947
Alzheimer Disease	Associate	17916554, 29371683, 8128960
Amyloidosis Familial	Associate	27297947, 30665372
Amyloidosis familial visceral	Associate	27297947
Cardiovascular Diseases	Associate	36690263
Cleft Palate	Associate	7668251
Colorectal Neoplasms	Associate	27992526
Coronary Disease	Associate	20498921
Coronary Stenosis	Associate	32327445
COVID 19	Associate	34232570
Diabetes Mellitus	Stimulate	32327445
Diabetes Mellitus Type 2	Associate	38003484
Down Syndrome	Associate	25476127
Dyskinesia Familial with Facial Myokymia	Associate	27297947
Dyslipidemias	Associate	31538826, 34921821, 38003484
Guillain Barre Syndrome	Stimulate	38143756
Hemolytic Uremic Syndrome	Inhibit	10412780
Hernia	Associate	23631828
Hyperlipidemias	Associate	16200213, 24646025
Hyperlipoproteinemia Type I	Inhibit	10225669, 3944267
Hyperlipoproteinemia Type I	Associate	10225669, 1479292, 1569385, 23470567, 2592354, 28201738, 29748148, 32205061, 32375710, 3379339, 3680515, 9017511
Hypersensitivity Immediate	Associate	7815420
Hypertriglyceridemia	Associate	10225669, 1569385, 23151256, 26772541, 29910226, 29921298, 30885219, 32115487, 35741823, 38003484, 3944267, 3944271, 6593704
Hypertriglyceridemia	Stimulate	35568684
Hypertriglyceridemic Waist	Associate	2341805, 9017511
Hypoalphalipoproteinemias	Stimulate	26667175
Hypobetalipoproteinemia Familial Apolipoprotein B	Associate	7815420
Hypogonadism	Associate	30665372
Hypoprothrombinemias	Associate	1569385, 28201738
Hypoprothrombinemias	Inhibit	28201738, 3379339
Immunologic Deficiency Syndromes	Inhibit	26772541
Kidney Diseases	Associate	27297947
Kidney Failure Chronic	Associate	22282592
Leukemia Megakaryoblastic Acute	Associate	25476127
Lymphatic Metastasis	Stimulate	37310025
Metabolic Diseases	Associate	36690263, 38003484
Metabolic Syndrome	Associate	28740125
Muscular Dystrophies	Associate	2562820
Myotonic Dystrophy	Associate	1672160, 1895314, 2002492, 2562820, 2575669, 2878705, 8279459
Neoplasms	Associate	36497182, 36690263
Pancreatitis	Associate	10225669, 26772541, 28201738, 36423940, 3944267
Plaque Amyloid	Associate	27297947
Plaque Atherosclerotic	Associate	17916554
Psychotic Disorders	Associate	28252112
Stomach Neoplasms	Associate	36430456
Urinary Bladder Neoplasms	Associate	23631828

APOC2 (apolipoprotein C2)